Page results
-
This information has been written for patients who are having total body irradiation (TBI) for a haematological cancer.
-
For people with autoimmune conditions, including multiple sclerosis (MS) and scleroderma: Collecting stem cells from your blood
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
-
This information will help you understand your forthcoming treatment and contains answers to many frequently asked questions.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
This page explains what autologous stem cell transplant is and includes information about our stem cell transplant service and process, the care patients will receive and what to expect after the transplant.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This page has been written for patients having proton beam therapy (PBT) at University College Hospital (UCH).
File results
-
FOI/2024/0690 - Mechanical transport ventilation/ ventway sparrow transport ventilator
-
FOI/2024/0691 - Information distributed to pregnant/ post-partum women for infant feeding
-
FOI/2024/0694 - Off-framework agency shifts/ spend/ contact details January-August 2024
-
FOI/2024/0702 - Community respiratory service mapping/ community-based bronchiectasis services
-
FOI/2024/0703 - Neurofibromatosis type 1 treatment/ volume of medication dispensed
-
FOI/2024/0704 - Contingencies to support visitors/ patients/ contractors witnessing a distressing event
-
FOI/2024/0716 - Toxicological screening/ testing/ training and information to patients
-
FOI/2024/0718 - Mental health/ electronic health records software/ dermatology screening/ imaging services/ medical devices for wound care
-
FOI/2024/0721 - New biologic and targeted medications/ treatment within dermatology
-
FOI/2024/0727 - Clinical photography solution contract/ spend